🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
BDX
NYSE
🇺🇸 US
Becton, Dickinson and Company
Healthcare
46Score
DipBuster Score™
$143.98
+$2.37 (+1.67%)
Live price · Source: Yahoo
52-Week Position
$127.59
27% of range
$187.35
Beta
0.278
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.278
52W High$187.35
52W Low$127.59
🤖
Watch — Score 46/100
Zone: Buy Zone
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position27% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.278
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Becton, Dickinson and Company free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
29/25
Momentum & Volume
12/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
🟡
Watch
DipBuster Score: 46/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supp…
Sector
Healthcare
Market
🇺🇸 US
CEO
Thomas E. Polen Jr.
Staff
70,000 employees
Website